Community acquired pneumonia. Pneumonia, unspecified organism
Conditions
Interventions
Intervention 1: Intervention group: They will receive 500 mg of the IMPOHelzavid herbal compound as 2 capsules every 12 hours for up to 72 hours. IMPOHelzavid contains a mixture of medicinal plants, i
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with pneumonia
Exclusion criteria
Exclusion criteria: Patients admitted in ICU Patients with uncontroled diabetes, hypertension and cardiovascular, respiratory, hepatic and renal underlying diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood oxygen saturation. Timepoint: At beginning and daily every 6 hours up to end of the study. Method of measurement: Pulse Oximeter.;Cough. Timepoint: At beginning and daily every 12 hours up to end of the study. Method of measurement: Cough evaluating questionnaire based on Visual Analog Scales.;Dyspnea. Timepoint: At beginning and daily every 12 hours up to end of the study. Method of measurement: Shortness of Breath with Daily Activities questionnaire (SOBDA). | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization. Timepoint: During the study. Method of measurement: Number of hospitalization day.;Need to mechanical ventilation. Timepoint: During the study. Method of measurement: If mechanical ventilation is required, the patient will be excluded from the study.;Mortality. Timepoint: During the study. Method of measurement: The number of expired patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhad Malek
Semnan University of Medical Sciences
Outcome results
None listed